| abrdn Healthcare Investors |
HQH |
πΊπΈ |
New York Stock Exchange |
$1.0bn |
|
| abrdn Healthcare Opportunities Fund |
THQ |
πΊπΈ |
New York Stock Exchange |
$755mn |
|
| Ambu AS - Class B Shares |
AMBU B |
π©π° |
Copenhagen Stock Exchange |
kr.25.0bn |
STOXX600 |
| Augmedix Inc |
AUGX |
πΊπΈ |
NASDAQ |
$116mn |
|
| Avita Medical Limited |
AVH |
π¦πΊ |
Australian Stock Exchange |
AU$963mn |
|
| Baxter International Inc. |
BAX |
πΊπΈ |
New York Stock Exchange |
$11.8bn |
S&P 100 S&P 500 |
| Bellevue Healthcare Trust Plc |
BBH |
π¬π§ |
London Stock Exchange |
Β£146mn |
|
| Cardinal Health, Inc. |
CAH |
πΊπΈ |
New York Stock Exchange |
$37.8bn |
S&P 500 |
| CareCloud Inc |
MTBC |
πΊπΈ |
NASDAQ |
$135mn |
|
| CareTech Holdings Plc |
CTH |
π¬π§ |
London Stock Exchange |
Β£850mn |
|
| Centene Corp. |
CNC |
πΊπΈ |
New York Stock Exchange |
$16.9bn |
S&P 500 |
| Cerner Corp. |
CERN |
πΊπΈ |
NASDAQ |
$27.9bn |
NASDAQ 100 S&P 500 |
| Chr. Hansen Holding |
CHR |
π©π° |
Copenhagen Stock Exchange |
kr.72.5bn |
OMX Copenhagen 20 STOXX600 |
| Cigna Group (The) |
CI |
πΊπΈ |
New York Stock Exchange |
$81.4bn |
S&P 500 |
| Clariane SE |
CLARI |
π«π· |
Euronext Paris |
β¬1.5bn |
|
| Clinica Baviera |
CBAV |
πͺπΈ |
Madrid Stock Exchange |
β¬722mn |
|
| Coloplast AS - Class B Shares |
COLO B |
π©π° |
Copenhagen Stock Exchange |
kr.126.6bn |
STOXX600 OMX Copenhagen 20 |
| Cooper Companies, Inc. |
COO |
πΊπΈ |
NASDAQ |
$14.8bn |
S&P 500 |
| Craneware Plc |
CRW |
π¬π§ |
London Stock Exchange |
Β£840mn |
|
| Creo Medical Group Plc |
CREO |
π¬π§ |
London Stock Exchange |
Β£45mn |
|
| Danaher Corp. |
DHR |
πΊπΈ |
New York Stock Exchange |
$157.3bn |
S&P 500 |
| DarioHealth Corp |
DRIO |
πΊπΈ |
NASDAQ |
$34mn |
|
| DaVita Inc |
DVA |
πΊπΈ |
New York Stock Exchange |
$9.2bn |
S&P 500 |
| Demant AS |
DEMANT |
π©π° |
Copenhagen Stock Exchange |
kr.50.5bn |
STOXX600 |
| DENTSPLY Sirona Inc |
XRAY |
πΊπΈ |
NASDAQ |
$2.6bn |
NASDAQ 100 S&P 500 |
| Edwards Lifesciences Corp |
EW |
πΊπΈ |
New York Stock Exchange |
$44.9bn |
S&P 500 |
| EKF Diagnostics Holdings plc |
EKF |
π¬π§ |
London Stock Exchange |
Β£125mn |
|
| Elekta AB - Class B Shares |
EKTA B |
πΈπͺ |
Stockholm Stock Exchange |
kr18.4bn |
STOXX600 |
| Elevance Health Inc |
ELV |
πΊπΈ |
New York Stock Exchange |
$77.0bn |
S&P 500 |
| EssilorLuxottica |
EL |
π«π· |
Euronext Paris |
β¬144.5bn |
Euro Stoxx 50 CAC 40 Euronext 100 STOXX600 |
| Essity Aktiebolag (publ) - Class B Shares |
ESSITY B |
πΈπͺ |
Stockholm Stock Exchange |
kr167.5bn |
STOXX600 |
| Euroapi S.A. |
EAPI |
π«π· |
Euronext Paris |
β¬307mn |
|
| Fresenius Medical Care AG & Co. KGaA |
FME |
π©πͺ |
Frankfurt Stock Exchange |
β¬13.7bn |
DAX 40 FTSE Eurotop 100 STOXX600 |
| Fresenius Medical Care AG & Co. KGaA - ADR |
FMS |
πΊπΈ |
New York Stock Exchange |
$15.8bn |
|
| Fresenius SE & Co. KGaA |
FRE |
π©πͺ |
Frankfurt Stock Exchange |
β¬26.9bn |
DAX 40 STOXX600 |
| Galenica AG |
GALE |
π¨π |
SIX Swiss Exchange |
Fr.4.6bn |
STOXX600 |
| Geberit AG |
GEBN |
π¨π |
SIX Swiss Exchange |
Fr.20.8bn |
STOXX600 |
| Haemonetics Corp. |
HAE |
πΊπΈ |
New York Stock Exchange |
$2.5bn |
|
| HCA Healthcare Inc |
HCA |
πΊπΈ |
New York Stock Exchange |
$103.0bn |
S&P Global 100 S&P 500 |
| Henry Schein Inc. |
HSIC |
πΊπΈ |
NASDAQ |
$7.7bn |
NASDAQ 100 S&P 500 |
| Humana Inc. |
HUM |
πΊπΈ |
New York Stock Exchange |
$35.0bn |
S&P 500 |
| Inspecs Group Plc |
SPEC |
π¬π§ |
London Stock Exchange |
Β£49mn |
|
| Inspiration Healthcare Group Plc |
IHC |
π¬π§ |
London Stock Exchange |
Β£14mn |
|
| Intuitive Surgical Inc |
ISRG |
πΊπΈ |
NASDAQ |
$197.6bn |
NASDAQ 100 S&P 500 |
| IQVIA Holdings Inc |
IQV |
πΊπΈ |
New York Stock Exchange |
$37.4bn |
S&P 500 |
| Kromek Group Plc |
KMK |
π¬π§ |
London Stock Exchange |
Β£46mn |
|
| Mediclinic International Plc |
MDC |
π¬π§ |
London Stock Exchange |
Β£3.7bn |
FTSE 350 CBOE 100 CBOE 350 FTSE 250 |
| Molina Healthcare Inc |
MOH |
πΊπΈ |
New York Stock Exchange |
$8.7bn |
S&P 500 |
| National Healthcare Corp. |
NHC |
πΊπΈ |
Markets exchange |
$1.9bn |
|
| Netcare Ltd |
NTC |
πΏπ¦ |
Johannesburg Stock Exchange |
R33.0bn |
|
| Novacyt |
ALNOV |
π«π· |
Euronext Paris |
β¬34mn |
|
| Oragenics Inc |
OGEN |
πΊπΈ |
Markets exchange |
$5mn |
|
| Orpea S.A. |
ORP |
π«π· |
Euronext Paris |
β¬2.3bn |
STOXX600 |
| Phibro Animal Health Corp. - Class A Shares |
PAHC |
πΊπΈ |
NASDAQ |
$836mn |
|
| PHSC |
PHSC |
π¬π§ |
London Stock Exchange |
Β£1mn |
|
| Poolbeg Pharma Plc |
POLB |
π¬π§ |
London Stock Exchange |
Β£24mn |
|
| Premier Inc - Class A Shares |
PINC |
πΊπΈ |
NASDAQ |
$2.3bn |
|
| Pro Medicus |
PME |
π¦πΊ |
Australian Stock Exchange |
AU$29.5bn |
|
| PureTech Health Plc |
PRTC |
π¬π§ |
London Stock Exchange |
Β£323mn |
FTSE 250 FTSE 350 |
| Ramsay Health Care |
RHC |
π¦πΊ |
Australian Stock Exchange |
AU$7.3bn |
|
| Renalytix Plc |
RENX |
π¬π§ |
London Stock Exchange |
Β£36mn |
|
| Resmed Inc. |
RMD |
πΊπΈ |
New York Stock Exchange |
$38.7bn |
S&P 500 |
| Resmed Inc. - Chess Depository Interest |
RMD |
π¦πΊ |
Australian Stock Exchange |
AU$60.1bn |
|
| RUA Life Sciences Plc |
RUA |
π¬π§ |
London Stock Exchange |
Β£7mn |
|
| Savaria Corp. |
SIS |
π¨π¦ |
Toronto Stock Exchange |
C$1.6bn |
|
| Sensus Healthcare Inc |
SRTS |
πΊπΈ |
NASDAQ |
$54mn |
|
| Smith & Nephew plc |
SN. |
π¬π§ |
London Stock Exchange |
Β£11.7bn |
FTSE 100 FTSE 350 CBOE 100 CBOE 350 STOXX600 |
| Spire Healthcare Group Plc |
SPI |
π¬π§ |
London Stock Exchange |
Β£967mn |
CBOE 250 CBOE 350 FTSE 250 FTSE 350 |
| Stericycle Inc. |
SRCL |
πΊπΈ |
NASDAQ |
$5.8bn |
NASDAQ 100 |
| Straumann Holding AG |
STMN |
π¨π |
SIX Swiss Exchange |
Fr.14.2bn |
STOXX600 |
| Stryker Corp. |
SYK |
πΊπΈ |
New York Stock Exchange |
$146.4bn |
S&P 500 |
| Teladoc Health Inc |
TDOC |
πΊπΈ |
New York Stock Exchange |
$1.5bn |
|
| Tenet Healthcare Corp. |
THC |
πΊπΈ |
New York Stock Exchange |
$18.3bn |
|
| Totally Health Plc |
TLY |
π¬π§ |
London Stock Exchange |
Β£0mn |
|
| Trellus Health Plc |
TRLS |
π¬π§ |
London Stock Exchange |
Β£1mn |
|
| Tristel |
TSTL |
π¬π§ |
London Stock Exchange |
Β£174mn |
|
| Unitedhealth Group Inc |
UNH |
πΊπΈ |
New York Stock Exchange |
$326.5bn |
Dow Jones 30 S&P 100 S&P 500 |
| Universal Health Services, Inc. - Class B Shares |
UHS |
πΊπΈ |
New York Stock Exchange |
$11.8bn |
S&P 500 |
| Vifor Pharma AG |
VIFN |
π¨π |
SIX Swiss Exchange |
Fr.10.8bn |
STOXX600 |
| Zepp Health Corporation - ADR |
ZEPP |
πΊπΈ |
New York Stock Exchange |
$314mn |
|
| Zimmer Biomet Holdings Inc |
ZBH |
πΊπΈ |
New York Stock Exchange |
$20.4bn |
S&P 500 |
| Zoetis Inc - Class A Shares |
ZTS |
πΊπΈ |
New York Stock Exchange |
$64.9bn |
S&P 500 |